Skip to main content
Smart Investors Daily
GN

OTC · GNGBY

Getinge AB (publ)

Healthcare · Medical - Devices

$27.33

Up+$0.00 (+0.00%)

Updated Oct 31, 2026, 2:09 AM

SID Score

6.0/10

Composite research score

Smart Money

46/100

Neutral

Market cap
6.15B
P/E ratio
27.86
Dividend yield
1.75%
52-week range
$18.99 – $27.33
Volume
536
Avg. volume
1.63K

Price performance · GNGBY

GNGBY price history

1M range · 15 trading sessions · Daily adjusted prices

Prices through Oct 28, 2026

GNGBY closed at $27.33 after 15 trading sessions, up 11.46% for the selected period.

Last close
$27.33
Period change
+11.46%
Period low
$24.52
Period high
$27.33
Daily close
View OHLC price history
GNGBY OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 28, 2026$27.33$27.33$27.33$27.33536
Oct 27, 2026$27.0525$27.0525$26.82$26.82744
Oct 23, 2026$26.865$26.865$26.82$26.822.91K
Oct 21, 2026$26.87$26.88$26.52$26.523.38K
Oct 19, 2026$26.225$26.225$26.225$26.225340
Oct 16, 2026$26.22$26.22$26.21$26.21511
Oct 15, 2026$25.995$25.995$25.995$25.995252
Oct 14, 2026$25.585$25.585$25.51$25.51887
Oct 13, 2026$25.39$25.4308$25.31$25.43082.09K
Oct 12, 2026$25.35$25.35$25.335$25.335765
Oct 9, 2026$25.415$25.415$25.31$25.322.3K
Oct 7, 2026$24.8325$24.91$24.79$24.912.69K
Oct 6, 2026$25.10$25.10$25.10$25.10481
Oct 5, 2026$24.68$24.90$24.68$24.901.29K
Oct 2, 2026$24.47$24.52$24.47$24.52797

Latest GNGBY news

The latest Smart Investors Daily articles mentioning GNGBY.

GNGBY research

Overview

Company profile and research snapshot.

Company profile

GETINGE AB UNSP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
GNGBY recent ratings
DateFirmRatingTarget
Jul 24, 2026EQUITA SIMHold—
Jul 20, 2026DNB CARNEGIEBuy—
Jul 20, 2026HANDELSBANKEN CAPITAL MARKETSHold—
Jul 20, 2026PARETO SECURITIES ASBuy—
Jul 14, 2026PARETO SECURITIES ASBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 22, 2026

Getinge (OM:GETI B) Q3 Earnings Strengthen The Margin Expansion Case

Getinge came into this Q3 2026 report with a quietly improving story, a 90 day return of about 15.6% and a P/E of 25.5x that sat slightly below both industry and peer averages. The fresh numbers added fuel. Q3 revenue reached SEK 8,446m and net income landed at SEK 719m, backed by an adjusted EBITA margin of 15.1% and strong free cash flow of SEK 1.3b. For a medical equipment group often viewed as a steady compounder rather than a headline grabber, that margin traction is what really...

Yahoo · Oct 19, 2026

SAP Stock And Large Cap Quality Shares With Steady Cash Flow Appeal

Markets are being hit with fresh regulatory shifts, new economic data and the prospect of changing monetary policy, and that mix is quietly redrawing the map for large‑cap quality stocks. When rates and rules move, stronger balance sheets and steadier cash flows can become more valuable, and missing those adjustments can mean missing meaningful opportunities. This article walks through three stocks from our screener that appear well exposed to these policy tailwinds. The three companies below...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.